VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 112 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $2,665,000 | +473.1% | 139,215 | +181.4% | 0.00% | +200.0% |
Q4 2018 | $465,000 | -75.2% | 49,465 | -50.0% | 0.00% | 0.0% |
Q3 2018 | $1,872,000 | +108.9% | 98,930 | +115.8% | 0.00% | 0.0% |
Q2 2018 | $896,000 | +16.7% | 45,844 | +12.2% | 0.00% | 0.0% |
Q1 2018 | $768,000 | +40.9% | 40,872 | +24.6% | 0.00% | 0.0% |
Q4 2017 | $545,000 | +14.5% | 32,814 | +42.0% | 0.00% | 0.0% |
Q3 2017 | $476,000 | +107.0% | 23,115 | -10.0% | 0.00% | – |
Q2 2017 | $230,000 | -15.8% | 25,685 | +24.7% | 0.00% | – |
Q1 2017 | $273,000 | +4.2% | 20,604 | 0.0% | 0.00% | – |
Q4 2016 | $262,000 | +16.4% | 20,604 | +9.8% | 0.00% | – |
Q3 2016 | $225,000 | +9.2% | 18,757 | 0.0% | 0.00% | – |
Q2 2016 | $206,000 | +303.9% | 18,757 | +220.0% | 0.00% | – |
Q1 2016 | $51,000 | -60.2% | 5,862 | 0.0% | 0.00% | – |
Q4 2015 | $128,000 | – | 5,862 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 3,185,291 | $24,558,594 | 29.60% |
EcoR1 Capital, LLC | 3,851,507 | $29,695,119 | 0.96% |
ARMISTICE CAPITAL, LLC | 3,524,000 | $27,170,040 | 0.39% |
EAM Investors, LLC | 123,818 | $954,637 | 0.19% |
HARBOURVEST PARTNERS LLC | 61,776 | $476,293 | 0.16% |
Diametric Capital, LP | 12,527 | $96,583 | 0.05% |
Campbell & CO Investment Adviser LLC | 30,563 | $235,641 | 0.04% |
CAXTON ASSOCIATES LP | 36,564 | $281,908 | 0.04% |
FIDUCIARY TRUST CO | 252,303 | $1,945,256 | 0.04% |
FARALLON CAPITAL MANAGEMENT LLC | 797,000 | $6,144,870 | 0.03% |